Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Referral Count:
0
Story being shared
Tangent secures $8.6M to bring IV catheter to market
Tangent Medical Technologies, a spinoff of the University of Michigan's Medical Innovation Center, obtained $8.6 million from nine backers in a round of equity financing. The money is expected to be used to market the company's NovaCath system, an FDA-cleared intravenous catheter designed to promote patient comfort, avoid blood spatters and protect patients from pathogen exposure.
MedCity News (11/29)
Or we can send an email on your behalf